Accepted for/Published in: JMIR Formative Research
Date Submitted: Jun 6, 2024
Date Accepted: Jul 10, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Development and Validation of a Convolutional Neural Network Model for Early Detection of Invasive Ductal Carcinoma in Histopathological Images
ABSTRACT
Breast cancer is a major health concern for women worldwide and poses a significant challenge to healthcare systems. According to the World Health Organization(WHO), 2.3 million women were diagnosed with breast cancer in 2020, resulting in 685,000 deaths. Invasive Ductal Carcinoma (IDC) accounts for 80% of these cases, making it crucial to accurately diagnose it in a timely manner. Traditional breast cancer detection methods rely on diagnostic imaging techniques like mammography, ultrasound, and MRI, which are interpreted by trained radiologists. However, these methods’ accuracy depends on the radiologist’s experience and can be subjective, leading to variability in diagnosis. False positives and negatives are not uncommon, which can result in missed cancers or unnecessary biopsies. This paper proposes a Deep Convolutional Neural Network (DCNN) based model to detect IDC in histopathological images of breast tissue. The model uses a robust dataset and fine-tuned hyperparameters, highlighting the potential of deep learning in improving diagnostic accuracy in oncology. The model achieved an 87% accuracy on the test set.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.